All In MedTech

Device Trial Radar · NCT03131544

MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)

Last checked: Nov 19, 2026Latest source record: Apr 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

10

Actual

Start

Apr 17, 2017

Primary completion

Oct 15, 2018

Study completion May 15, 2020

Sponsor

Lead sponsor
Prostate Laser Center, PLLCNot on our public-company list
Sponsor type
Industry
Collaborators
Medtronic
First posted
Apr 27, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Over 100,000 BPH procedures are performed annually in the US. The purpose of this study is to evaluate the effectiveness of performing MRI guided transrectal laser ablation using a 980 nm laser (VisualaseTM by Medtronic, Inc., a Minnesota, U.S.A. company) to treat benign prostatic hypertrophy (BPH). The laser system will be used to necrotize urological soft tissue within the prostate under MRI guidance. This will be a single center, single arm prospective trial with an anticipated enrollment of 10 men. Patients who elect this treatment option and choose to be part of the study will be enrolled consecutively.

Conditions

  • BPH
  • Prostate Hyperplasia
  • Urinary Frequency/Urgency

Interventions

  • MRI Guided Transrectal Periuretheral Transitional Zone AblationDevice

    Patients will undergo an MRI guided transrectal ablation of tissue within the periuretheral transitional zone.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. International Prostate Symptom Score (IPSS) ChangeTime frame: From baseline to 2 months
  2. International Prostate Symptom Score (IPSS) Quality of Life (QoL) Question ChangeTime frame: From baseline to 2 months
  3. BPH Impact Index ChangeTime frame: From baseline to 2 months

14 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Prostate Laser Center, PLLC

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.